AI assistant
Tatva Chintan Pharma Chem Limited — Call Transcript 2021
Oct 21, 2021
59570_rns_2021-10-21_0d59710f-a315-4d59-851c-edefdd3d844e.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [521 x 81] intentionally omitted <==
Ref No: TCPCL/SEC/2021-22/00027
Date: 21 October 2021
To,
| The General Manager, Corporate relationship department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400 001 Scrip Code: 543321 Through: BSE Corporate Compliance & Listing Centre |
The Manager, Listing department, National Stock Exchange of India Limited Exchange Plaza, C-1, Block-G, Bandra-Kurla, Complex Bandra(E), Mumbai-400 051 Scrip Symbol: TATVA Through: NEAPS |
|
|---|---|---|
Sub: Intimation of Schedule of Earnings Call
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and half year ended 30 September 2021, is scheduled on Monday, 25 October 2021 at 16:00 hours (IST).
The Call is hosted by B&K Securities India Private Limited and an invite in this regard is attached for your information and records.
Thanking you.
Yours faithfully.
Tatva Chintan Pharma Chem Limited
==> picture [69 x 31] intentionally omitted <==
==> picture [28 x 29] intentionally omitted <==
Apurva Dubey
Company Secretary And Compliance Officer
Membership No: A41130
As encl
Factory and Registered Office : Plot No. 502/17, G.I.D.C. Estate, Ankleshwar - 393 002, District:Bharuch, Gujarat, India.
SEZ Unit: Plot No. Z/103/F/1 and Plot No. Z/103/F/2, SEZ Area Part-2 , Dahej - 392 130, District: Bharuch, Gujarat, India.
DSIR Approved R & D Centre: Plot No. 353, G.I.D.C., Makarpura, Vadodara - 390 010, Gujarat, India. Telephone No. +91 75748 48533 / 34 Fax : +91 265 263 8533
E-mail: [email protected] Website : www.tatvachintan.com
==> picture [130 x 86] intentionally omitted <==
CONCALL INVITE
B&K Securities is pleased to invite you to
the Conference Call of
Tatva Chintan Pharma Chem Ltd.
to discuss the Q2FY22 Financial performance on Monday, 25th October 2021 at 04:00 pm IST
Management Representatives:
Mr. Chintan Shah – Managing Director,
Mr. Dinesh Sodani – GM – Accounts and Finance
Diamond Pass Link
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=1724 510&linkSecurityString=69ee2768e
Dial-in Numbers
Primary Access: +91 22 6280 1222 / +91 22 7115 8123
International Toll Free:
USA: 1 866 746 2133
UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448
For further information, please contact
Mr. Ranjit Cirumalla
Batlivala & Karani Securities India Pvt. Ltd.
+91 22 4031 7127